0001415889-24-016068.txt : 20240607
0001415889-24-016068.hdr.sgml : 20240607
20240607182255
ACCESSION NUMBER: 0001415889-24-016068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brege Laura
CENTRAL INDEX KEY: 0001365619
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 241031029
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 2100 POWELL STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4-06072024_100651.xml
X0508
4
2024-06-05
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001365619
Brege Laura
C/O MIRUM PHARMACEUTICALS, INC.
989 E HILLSDALE BLVD., SUITE 300
FOSTER CITY
CA
94404
true
false
false
false
1
Stock Option (right to buy)
26.30
2024-06-05
4
A
0
8779
0
A
2034-06-04
Common Stock
8779
8779
D
Restricted Stock Units
2024-06-05
4
A
0
5703
0
A
Common Stock
5703
5703
D
The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting.
/s/ Judit Ryvkin, Attorney-in-Fact
2024-06-07